IRAZÚ Bio-Holdings
IRAZÚ Bio-Holdings bridges the gap between academic research and drug development by partnering with academic investigators and university centers to accelerate translational research into clinical applications. The company focuses on increasing the value of transformative intellectual property assets and either licenses these to pharmaceutical companies or forms new ventures with VC groups. Their mission is to leverage natural biochemical mechanisms and innovative research to promote survival, prevent disease, and improve quality of life, especially in the context of neuroprotection, immuno-oncology, and gene therapy.
IRAZÚ Bio-Holdings
801 W. Baltimore Street, Suite 518, Baltimore, MD 21201
What We Do
Development of applications based on natural biochemical mechanisms (e.g., caloric restriction, hibernation) to promote survival, prevent disease, and improve quality of life, particularly in aging.
Platform to induce global immunity targeting unique tumor antigens, developed in partnership with leading research labs for cancer treatment.
Expertise in gene therapy process development and manufacturing of Adeno-Associated Virus (AAV), seeking new projects and partners for rare and orphan disease therapies.
Partnerships with Principal Investigators and university-based Centers of Excellence to accelerate translational research into IND-enabling studies and Phase 1 clinical trials.
Hands-on identification and value enhancement of transformative, vetted intellectual property assets.
Licensing of lower risk, higher value IP assets to pharma companies for clinical development, or formation of new companies in collaboration with venture capital groups.
Key People
Lab Manager
News & Updates
Announcement of Isabel Sonam's participation as a speaker at the World Fashion Convention in New York City.
Spencer Ingram featured in an interview with DeCode, discussing relevant topics in design, tech, and venture capital.
Article offering free legal advice for creative professionals, covering art, music, and film.
Bradley Cawthern quoted in an ethics review publication.
Angeline Harris and Spencer Ingram participate as panelists at the Inventor's Symposium, discussing intellectual property.
Article providing legal guidance for creative agencies, authored by Bradley Cawthern.